These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pelvic exenteration for primary and recurrent gynaecological malignancies. de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559 [TBL] [Abstract][Full Text] [Related]
7. Pelvic exenteration. Has it a role in 1987? A six year experience. Shepherd JH Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684 [TBL] [Abstract][Full Text] [Related]
8. Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis. Kraybill WG; Lopez MJ; Bricker EM Surg Gynecol Obstet; 1988 Mar; 166(3):259-63. PubMed ID: 3344455 [TBL] [Abstract][Full Text] [Related]
9. [Preliminary experience with the Miami type ileocolonic urinary reservoir in the practice of oncologic gynecology]. Sánchez-Valdivieso E; González Enciso A; Herrera Gómez A; Chávez Montes de Oca V; Muñóz González D Arch Esp Urol; 2001 May; 54(4):327-33. PubMed ID: 11455766 [TBL] [Abstract][Full Text] [Related]
10. Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies. Husain A; Curtin J; Brown C; Chi D; Hoskins W; Poynor E; Alektiar K; Barakat R Gynecol Oncol; 2000 Aug; 78(2):208-11. PubMed ID: 10926804 [TBL] [Abstract][Full Text] [Related]
11. Choices in creating continent urostomies following pelvic exenteration for gynecologic malignancies. Silver DF; Ashwell TR Gynecol Oncol; 2001 Sep; 82(3):510-5. PubMed ID: 11520148 [TBL] [Abstract][Full Text] [Related]
12. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients. Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266 [TBL] [Abstract][Full Text] [Related]
14. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy. Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120 [TBL] [Abstract][Full Text] [Related]
15. Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome. Andikyan V; Khoury-Collado F; Gerst SR; Talukdar S; Bochner BH; Sandhu JS; Abu-Rustum N; Sonoda Y; Barakat RR; Chi DS Gynecol Oncol; 2012 Sep; 126(3):346-50. PubMed ID: 22555107 [TBL] [Abstract][Full Text] [Related]
16. Pelvic exenteration: long-term oncological results in a series of 106 patients. De Wever I Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128 [TBL] [Abstract][Full Text] [Related]
17. Indications for primary and secondary exenterations in patients with cervical cancer. Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276 [TBL] [Abstract][Full Text] [Related]
18. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer. Berek JS; Hacker NF; Lagasse LD Obstet Gynecol; 1984 Nov; 64(5):715-20. PubMed ID: 6387559 [TBL] [Abstract][Full Text] [Related]
19. Pelvic exenteration for gynecological malignancies: an analysis of 15 cases operated on at a single institution. Mäenpää JU; Kangasniemi K; Luukkaala T Acta Obstet Gynecol Scand; 2010; 89(2):279-83. PubMed ID: 19916881 [TBL] [Abstract][Full Text] [Related]